Our findings demonstrate that incorporating cystatin C-based eGFR, particularlyeGFRcys-cr using the CKD-EPI 2021 equations, significantly enhances theprediction of MACEs in this population compared to traditional creatinine-basedmeasures alone. The gene discussed is CST3; the disease is chronic kidney disease.